Beta-alanine Supplementation and High-intensity Interval Training
NCT ID: NCT03708185
Last Updated: 2021-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2018-06-04
2021-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Beta-alanine and Elder Endurance
NCT02821481
The Effect of β-hydroxy-β-methylbutyrate Supplementation on Physical Capacity and Body Composition in Trained Athletes
NCT03028649
Effect of Beta-Alanine on Heart Rate Response
NCT01745016
Beta-alanine Supplementation and CrossFit Performance
NCT05772988
The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s
NCT03111979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Energy for the contraction of muscles is created in the mitochondria. HIIT can improve the function of mitochondria, therefore improving performance.
Β-alanine is a commonly used supplement that can improve exercise performance by increasing the amount of carnosine in muscle. Carnosine has many functions that may help improve exercise capacity.
The present study will seek to quantify whether a period of HIIT alongside β-alanine supplementation will improve the adaptation to training, and therefore performance, more than a period of HIIT alone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIIT + beta-alanine
Participants will ingest an active supplement containing beta-alanine for a period of 12 weeks. During the last 8 weeks of that period, participants will take part in a structured program of high-intensity interval training.
Beta-alanine
N/A: see arm description
HIIT + placebo
Participants will ingest a placebo supplement containing no beta-alanine for a period of 12 weeks. During the last 8 weeks of that period, participants will take part in a structured program of high-intensity interval training.
Placebo
N/A: see arm description
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beta-alanine
N/A: see arm description
Placebo
N/A: see arm description
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females must be taking an oral contraceptive, or using a contraceptive implant.
Exclusion Criteria
* Diagnosed cardiovascular or metabolic disease
* Regular use of beta-alanine supplements
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Exeter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew D Davenport, MSc
Role: PRINCIPAL_INVESTIGATOR
The University of Exeter
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Sport and Health Sciences
Exeter, Devon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
180509/B/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.